Top experts by indication / Oncology
Most active experts in Leukemia (AML/ALL/CML/CLL)
2026 edition, data as of October 26, 2026
1,679 key opinion leaders in the directory are tagged to Leukemia (AML/ALL/CML/CLL). The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.
Most registered trials
Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 651 of the 1,679 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.
| # | Expert | trials |
|---|---|---|
| 1 | Jorge CortesUniversity of Alabama at Birmingham (UAB), AL | 58 trials |
| 2 | Elias JabbourThe University of Texas MD Anderson Cancer Center, TX | 38 trials |
| 3 | Farhad Ravandi-KashaniThe University of Texas MD Anderson Cancer Center, TX | 27 trials |
| 4 | Guillermo Garcia-ManeroThe University of Texas MD Anderson Cancer Center, TX | 25 trials |
| 5 | Hagop KantarjianThe University of Texas MD Anderson Cancer Center, TX | 24 trials |
| 6 | Tapan KadiaThe University of Texas MD Anderson Cancer Center, TX | 22 trials |
| 7 | Richard ChamplinThe University of Texas MD Anderson Cancer Center, TX | 22 trials |
| 8 | Nitin JainThe University of Texas MD Anderson Cancer Center | 21 trials |
| 9 | Robert KreitmanNational Cancer Institute, MD | 21 trials |
| 10 | Brenda SandmaierFred Hutchinson Cancer Center, WA | 21 trials |
| 11 | Courtney DiNardoThe University of Texas MD Anderson Cancer Center, TX | 20 trials |
| 12 | Gautam BorthakurThe University of Texas MD Anderson Cancer Center, TX | 19 trials |
| 13 | Wendy StockUniversity of Chicago, IL | 19 trials |
| 14 | Alessandra FerrajoliThe University of Texas MD Anderson Cancer Center, TX | 18 trials |
| 15 | William WierdaThe University of Texas MD Anderson Cancer Center, TX | 18 trials |
| 16 | Naval DaverThe University of Texas MD Anderson Cancer Center, TX | 17 trials |
| 17 | Anthony SteinCity of Hope, CA | 16 trials |
| 18 | Geoffrey UyWashington University School of Medicine, MO | 16 trials |
| 19 | Olatoyosi OdenikeUniversity of Chicago, IL | 16 trials |
| 20 | Judith KarpJohns Hopkins University School of Medicine, MD | 15 trials |
| 21 | Ibrahim AldossCity of Hope, CA | 15 trials |
| 22 | Anjali AdvaniCleveland Clinic, OH | 15 trials |
| 23 | Mitchell CairoNew York Medical College, NY | 14 trials |
| 24 | Eunice WangRoswell Park Comprehensive Cancer Center, NY | 14 trials |
| 25 | Jennifer WoyachThe Ohio State University, OH | 14 trials |
Most cited
Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 271 of the 1,679 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.
| # | Expert | citations |
|---|---|---|
| 1 | Hagop KantarjianThe University of Texas MD Anderson Cancer Center, TX | 270,473 citations |
| 2 | Scott SolomonBrigham and Women's Hospital, MA | 187,732 citations |
| 3 | Jorge CortesUniversity of Alabama at Birmingham (UAB), AL | 144,714 citations |
| 4 | Thomas WalshCornell University, NY | 105,956 citations |
| 5 | Charles SawyersMemorial Sloan Kettering Cancer Center, NY | 104,223 citations |
| 6 | John DipersioWashington University School of Medicine, MO | 98,282 citations |
| 7 | Brian DrukerOregon Health & Science University, OR | 95,799 citations |
| 8 | Shaji KumarMayo Clinic, MN | 95,766 citations |
| 9 | Guillermo Garcia-ManeroThe University of Texas MD Anderson Cancer Center, TX | 90,546 citations |
| 10 | Martin TallmanNorthwestern University Feinberg School of Medicine, IL | 89,799 citations |
| 11 | Razelle KurzrockMedical College of Wisconsin, WI | 88,610 citations |
| 12 | Richard ChamplinThe University of Texas MD Anderson Cancer Center, TX | 77,241 citations |
| 13 | Richard StoneDana-Farber Cancer Institute, MA | 77,206 citations |
| 14 | Daniel WeisdorfUniversity of Minnesota Medical School, MN | 76,789 citations |
| 15 | Michael AndreeffThe University of Texas MD Anderson Cancer Center, TX | 74,861 citations |
| 16 | Howard BurrisSarah Cannon Research Institute, TN | 72,593 citations |
| 17 | Marina KonoplevaAlbert Einstein College of Medicine | 71,749 citations |
| 18 | Farhad Ravandi-KashaniThe University of Texas MD Anderson Cancer Center, TX | 71,079 citations |
| 19 | Mario SznolUniversity of Miami Miller School of Medicine, FL | 69,239 citations |
| 20 | Stephan GruppChildren's Hospital of Philadelphia, PA | 64,125 citations |
| 21 | Sergio GiraltMemorial Sloan Kettering Cancer Center, NY | 63,367 citations |
| 22 | William WierdaThe University of Texas MD Anderson Cancer Center, TX | 63,208 citations |
| 23 | Thomas WitzigMayo Clinic, MN | 62,686 citations |
| 24 | Francis GilesTX | 60,986 citations |
| 25 | Stephen FormanCity of Hope, CA | 60,700 citations |
Most NIH awards
NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 189 of the 1,679 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: NIH RePORTER.
| # | Expert | awards |
|---|---|---|
| 1 | Hans-Peter KiemWA | 31 awards |
| 2 | Lee RatnerMO | 26 awards |
| 3 | Michael AndreeffThe University of Texas MD Anderson Cancer Center, TX | 20 awards |
| 4 | Catherine WuMA | 19 awards |
| 5 | Li LiCA | 17 awards |
| 6 | Scott KaufmannMayo Clinic, MN | 17 awards |
| 7 | John DipersioWashington University School of Medicine, MO | 15 awards |
| 8 | Roland WalterFred Hutchinson Cancer Center, WA | 14 awards |
| 9 | Edmund WallerEmory University, GA | 13 awards |
| 10 | Jeffrey MillerUniversity of Minnesota Medical School, MN | 13 awards |
| 11 | Marina KonoplevaAlbert Einstein College of Medicine | 12 awards |
| 12 | Malcolm BrennerBaylor College of Medicine, TX | 12 awards |
| 13 | Brenda SandmaierFred Hutchinson Cancer Center, WA | 11 awards |
| 14 | Brian DrukerOregon Health & Science University, OR | 11 awards |
| 15 | Zihai LiOH | 10 awards |
| 16 | Daniel WeisdorfUniversity of Minnesota Medical School, MN | 10 awards |
| 17 | Neil KayMayo Clinic, MN | 10 awards |
| 18 | Richard JonesJohns Hopkins University School of Medicine, MD | 10 awards |
| 19 | Robert NegrinStanford University School of Medicine, CA | 10 awards |
| 20 | Stephen FormanCity of Hope, CA | 9 awards |
| 21 | Stephan GruppChildren's Hospital of Philadelphia, PA | 9 awards |
| 22 | Mitchell CairoNew York Medical College, NY | 9 awards |
| 23 | Charles SawyersMemorial Sloan Kettering Cancer Center, NY | 9 awards |
| 24 | Richard AplencChildren's Hospital of Philadelphia, PA | 8 awards |
| 25 | Steven GoreMD | 8 awards |
Most congress contributions
Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 105 of the 1,679 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: Congress abstracts, DOI-verified.
| # | Expert | contributions |
|---|---|---|
| 1 | Hagop KantarjianThe University of Texas MD Anderson Cancer Center, TX | 859 contributions |
| 2 | Farhad Ravandi-KashaniThe University of Texas MD Anderson Cancer Center, TX | 677 contributions |
| 3 | Jorge CortesUniversity of Alabama at Birmingham (UAB), AL | 654 contributions |
| 4 | Shaji KumarMayo Clinic, MN | 449 contributions |
| 5 | Michael AndreeffThe University of Texas MD Anderson Cancer Center, TX | 319 contributions |
| 6 | Ghayas IssaThe University of Texas MD Anderson Cancer Center, TX | 275 contributions |
| 7 | Ian FlinnTennessee Oncology, TN | 242 contributions |
| 8 | Richard StoneDana-Farber Cancer Institute, MA | 242 contributions |
| 9 | Guido MarcucciCity of Hope, CA | 240 contributions |
| 10 | Thomas WitzigMayo Clinic, MN | 240 contributions |
| 11 | Daniel DeangeloDana-Farber Cancer Institute, MA | 229 contributions |
| 12 | Prithviraj BoseThe University of Texas MD Anderson Cancer Center, TX | 223 contributions |
| 13 | Eunice WangRoswell Park Comprehensive Cancer Center, NY | 222 contributions |
| 14 | Elizabeth ShpallThe University of Texas MD Anderson Cancer Center, TX | 217 contributions |
| 15 | Eric PadronUniversity of South Florida (USF Health), FL | 217 contributions |
| 16 | Wendy StockUniversity of Chicago, IL | 210 contributions |
| 17 | Gail RobozWeill Cornell Medicine, NY | 208 contributions |
| 18 | Partow KebriaeiThe University of Texas MD Anderson Cancer Center, TX | 202 contributions |
| 19 | Mazyar ShadmanFred Hutchinson Cancer Center, WA | 199 contributions |
| 20 | Gary SchillerUniversity of California, Los Angeles, CA | 193 contributions |
| 21 | Sikander AilawadhiMayo Clinic, FL | 185 contributions |
| 22 | Ravi VijWashington University School of Medicine in St. Louis, MO | 184 contributions |
| 23 | Maria BaerUniversity of Maryland School of Medicine, MD | 180 contributions |
| 24 | Andrew ZelenetzMemorial Sloan Kettering Cancer Center, NY | 179 contributions |
| 25 | Alessandra FerrajoliThe University of Texas MD Anderson Cancer Center, TX | 177 contributions |
Emerging
97 of the 1,679 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.
| Nabil AhmedHouston Methodist, TX |
| Inhye AhnHarvard University, MA |
| Othman AkhtarMedical College of Wisconsin, WI |
| Melissa AlsinaMoffitt Cancer Center, FL |
| Maria AmayaUniversity of Colorado Anschutz, CO |
| Kayleen BaileyNY |
| Frank BalisChildren's Hospital of Philadelphia, PA |
| Diana BasaliCleveland Clinic, OH |
| David BectonUniversity of Arkansas for Medical Sciences, AR |
| Rafael BejarUniversity of California, San Diego, CA |
| Uma BorateThe Ohio State University, OH |
| Brett BrinkerMI |
| Sharon CastellinoEmory University, GA |
| Jordan ChinaiBroad Institute, MA |
| Nicholas ChiorazziNorthwell Health, NY |
| David ChittyNorthwell Health, NY |
| Jeremy ConnorsThe University of Texas MD Anderson Cancer Center, TX |
| Saurabh DahiyaCA |
| Kenneth DesantesUniversity of Wisconsin–Madison, WI |
| Alexandra DreyzinDC |
| Omotayo FasanUniversity of Pennsylvania, NC |
| Sara FedericoSt. Jude Children's Research Hospital, TN |
| Timothy FerngNY |
| Antonio FojoColumbia University Irving Medical Center, NY |
| Peter ForsbergCO |
How these tables are computed
The cohort is every profile in the directory tagged to Leukemia (AML/ALL/CML/CLL), from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.
Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.
The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.
What is deliberately absent
Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.
Filter, sort and open every Leukemia (AML/ALL/CML/CLL) profile in the directory